Výsledky vyhledávání

< Back Enantis – first biotechnology spin-off from Masaryk University in Brno Enantis s.r.o. was founded in 2006 as the first biotechnology spin-off from Masaryk University in Brno , Czech Republic. Project went through long development and its expertise is now based on vast experience in protein science and state-of-the-art software tools. A combination which enables Enantis to provide protein engineering and production. Enantis s.r.o. now located at INBIT, biotechnology centre operated by JIC and located on Masaryk University’s campus and closely collaborate with Loschmidt Laboratories and other research institutions. They are predominantly focused on improving the poor stability eg. of fibroblast growth factors (FGFs) for research and therapeutic use. Enantis offers contract research services and licensing of their original products and the company already collaborate on the B2B level with multiple international companies. ​ Under current difficult circumstances Enantis are one of the key suppliers of research products. They also became a member of FASTCURE ( https://fastcure.net/ ) consortium recently. ​ i&i Prague and Enantis started a collaboration in 2017 and it is based on consultations and business development support of the Enantis team. ​ To learn more about this company: Enantis s.r.o. webpage. Previous Next

< Back Jaromír Zahrádka Business development Jaromir is the co-founder of i&i Prague, a Bio-Innovation Centre and incubator established within the ecosystem of the Institute of Organic Chemistry and Biochemistry of the AS CR. In 2021, he also became the founder and Managing Partner of the i&i Biotech Fund, a unique early-phase investment fund with more than 45 million EUR under management. The fund has teams in Luxembourg and Prague, and it focuses on investments in European Life Science start-ups with global potential. Under his leadership, these companies have developed into respected partners of Czech and European scientific institutions, spin-offs, and other international investors. In his 10 years of experience in the field of technology transfer and investment, Jaromír has been involved in the management of many successful projects on the C-level and served on multiple boards. Together with his team, he has supported or invested in more than 15 biotech spin-off companies from more than 6 countries. Jaromír holds a Ph.D. in Biochemistry from Charles University in Prague. He also completed a Master’s degree in Corporate Economics, Management, and Enterprise Valuation at the University of Economics in Prague. Using his economic background in combination with his scientific expertise, he will provide a complex perspective for the evaluation of your project´s potential and feasibility. He will help you find the right strategy and attract investors or licensing partners and he will make the numbers play in your favor. His expertise and network of contacts including investors and Big Pharma can open a brand-new perspective for your project.

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

< Back i&i Prague became a shareholder in the spin-off XENO Cell Innovations! XENO Cell Innovations is a young, progressing company based in Pilsen, Czech Republic. It is focused mostly on bio-computing – capturing complex biological system in images, combining creative microscopy with a little narration and a lot of imagination to make more visible the amazing potential of computing in liquid media. Their technology is able to link up to biological objects generating a coherent intelligible interface. It self-assembles into computational clusters and processes information locally within these clusters. Rather than relying on brute-force screening, the linked biological sample reports on itself. Categorically, a cluster is a physically connected network made up of genetically engineered yeast, linkers, enzymes, and other chemical modifiers. Clusters are not prefabricated. They self-assemble around objects with specific immunological profiles. By fusing different fluorescent labels to different yeast strains, the makeup of a cluster can in part be made visible. ​ We, the i&i Prague, had this great opportunity to offer our services to this project and helped its creators reach their goal. Now, with the company established, we became a proud shareholder! ​ The motto of XENO Cell Innovations is: „Many foundational problems in diagnostics and bioengineering are solvable if biology could just do more of the work. But current biotech isn’t smart enough. We are interested in changing the status quo by systematizing biologic units and constructing modular composition rules“ . ​ To find out more about this growing company, SEARCH: https://xenocells.com/ Previous Next